Acquired by Acelity/KC1
Commercial stage company with novel devices allowing portable, non-powered products for negative pressure chronic wound therapy.
Sunnyvale, CA
Commercial stage company with novel devices allowing portable, non-powered products for negative pressure chronic wound therapy.
Sunnyvale, CA
Location: United States, California, Sunnyvale
Employees: 51-200
Total raised: $55.3M
Founded date: 2007
Investors 1
| Date | Name | Website |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.02.2011 | - | $35M | - |
| 25.06.2009 | - | $20.3M | - |
Mentions in press and media 3
| Date | Title | Description |
| 12.11.2014 | Spiracur raises $16m from GE Capital | Spiracur said today that it raised $16 million debt round from GE Capital for its negative-pressure wound therapy device. Sunnyvale, Calif.-based Spiracur said it plans to use the proceeds to launch new products, penetrate new care settings... |
| 01.02.2011 | Spiracur Closes $35M Equity Financing | Spiracur, Inc., a Sunnyvale, Calif.-based developer of an ultraportable and single-use, negative pressure wound therapy (NPWT) device, closed a $35m round of equity financing. The round was led by new investor Maverick Capital, with partici... |
| 25.06.2009 | Spiracur takes $20.3M for effective wound healing | Spiracur, developer of a device used to heal small wounds effectively, has brought in $20.3 million in a second round of funding from Kleiner Perkins Caufield & Byers, New Leaf Venture Partners and De Novo Ventures, reports VentureWire.... |